Samuel J. Reich - Nov 17, 2021 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Executive Chairman, Director
Signature
/s/ Samuel J. Reich
Stock symbol
SABS
Transactions as of
Nov 17, 2021
Transactions value $
$0
Form type
4
Date filed
11/19/2021, 03:05 PM
Previous filing
Oct 15, 2021
Next filing
Mar 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Employee Stock Option (right to buy) Award $0 +350K $0.00 350K Nov 17, 2021 Common Stock 350K $11.17 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options to purchase shares of common stock granted to the Reporting Person pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
F2 The shares underlying the option vest over a three-year period, vesting 1/3 on the one-year anniversary of the date of grant, and the remaining 2/3 vesting pro rata on a monthly basis in 24 equal installments thereafter.